Given the high degree of heterogeneity in B-cell malignancies, analysis of clinical specimens will be required to fully appreciate the implications of ROCK2 signaling in ABC-DLBCL. The gene discussed is ROCK2; the disease is diffuse large B-cell lymphoma.